Evidence map›Paper›PMID 36005812›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2022

Biomarkers of Alzheimer syndrome and related dementias: A&D author's guide.

Michael W Lutz, Ara S Khachaturian, Henrik Zetterberg, Kaj Blennow, Auriel A Willette, Michelle M Mielke, Kathleen M Hayden, Hiroko H Dodge, Yi Tang, Barry D Greenberg and 2 more

Abstract readEditorial
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. History of Alzheimer's Disease Research Centers: From inception in 1984 to evolution beyond 2025.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  3. Perspective: Emerging challenges for a future ADNI.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Michael W LutzDepartment of Neurology, Duke University School of Medicine, Durham, NC, USA.
Ara S KhachaturianAlzheimer's & Dementia: The Journal of the Alzheimer's Association, Rockville, MD, USA.
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Kaj BlennowInstitute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Auriel A WilletteDepartment of Food Science and Human Nutrition, Iowa State University, Ames, IA, USA.
Michelle M MielkeDepartment of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Kathleen M HaydenDepartment of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Hiroko H DodgeDepartment of Neurology, Layton Aging and Alzheimer's Disease Center, Oregon Health & Science University, Portland, OR, USA.
Yi TangDepartment of Neurology, Innovation Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, National Center for Neurological Disorders, Beijing, China.
Barry D GreenbergDepartment of Neurology, Director, Alzheimer's Disease Translational Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Walter A KukullDepartment of Epidemiology, University of Washington, Seattle, WA, USA.
Zaven S KhachaturianAlzheimer's & Dementia: The Journal of the Alzheimer's Association, Rockville, MD, USA.

Funding

Research Education ComponentP30AG066518 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Zachary Beattie · 2020 to 2026
$28.6M
Wake Forest University School of Medicine Alzheimer's Disease Research CenterP30AG072947 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SUZANNE CRAFT · 2021 to 2026
$24.3M
NIA NIH HHS P30 AG066518NIA NIH HHS P30 AG072947
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer DiseaseDementiaBiomarkersHumansBiomarkers

Identifiers

PMID36005812
PMCPMC9514317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.